Report Detail
Global (United States, European Union and China) Generic Injectables Market Research Report 2019-2025
- RnM3669980 |
- 14 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc.
In 2019, the market size of Generic Injectables is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Generic Injectables.
This report studies the global market size of Generic Injectables, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Generic Injectables sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Sandoz International
Baxter
Fresenius
Mylan
Teva Pharmaceutical
Hikma Pharmaceuticals
Lupin Pharmaceuticals
Sanofi
Biocon
Market Segment by Product Type
Large Molecule Injectables (Biosimilars)
Small Molecule Injectables
Market Segment by Application
Oncology
Infectious Diseases
Cardiology
Diabetes
Immunology
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Generic Injectables status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Generic Injectables manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Generic Injectables are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Generic Injectables Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Large Molecule Injectables (Biosimilars)
- 1.3.3 Small Molecule Injectables
- 1.4 Market Segment by Application
- 1.4.1 Global Generic Injectables Market Share by Application (2019-2025)
- 1.4.2 Oncology
- 1.4.3 Infectious Diseases
- 1.4.4 Cardiology
- 1.4.5 Diabetes
- 1.4.6 Immunology
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Generic Injectables Market Size
- 2.1.1 Global Generic Injectables Revenue 2014-2025
- 2.1.2 Global Generic Injectables Sales 2014-2025
- 2.2 Generic Injectables Growth Rate by Regions
- 2.2.1 Global Generic Injectables Sales by Regions 2014-2019
- 2.2.2 Global Generic Injectables Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Generic Injectables Sales by Manufacturers
- 3.1.1 Generic Injectables Sales by Manufacturers 2014-2019
- 3.1.2 Generic Injectables Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Generic Injectables Revenue by Manufacturers (2014-2019)
- 3.2.2 Generic Injectables Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Generic Injectables Market Concentration Ratio (CR5 and HHI)
- 3.3 Generic Injectables Price by Manufacturers
- 3.4 Key Manufacturers Generic Injectables Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Generic Injectables Market
- 3.6 Key Manufacturers Generic Injectables Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Large Molecule Injectables (Biosimilars) Sales and Revenue (2014-2019)
- 4.1.2 Small Molecule Injectables Sales and Revenue (2014-2019)
- 4.2 Global Generic Injectables Sales Market Share by Type
- 4.3 Global Generic Injectables Revenue Market Share by Type
- 4.4 Generic Injectables Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Generic Injectables Sales by Application
6 United States
- 6.1 United States Generic Injectables Breakdown Data by Company
- 6.2 United States Generic Injectables Breakdown Data by Type
- 6.3 United States Generic Injectables Breakdown Data by Application
7 European Union
- 7.1 European Union Generic Injectables Breakdown Data by Company
- 7.2 European Union Generic Injectables Breakdown Data by Type
- 7.3 European Union Generic Injectables Breakdown Data by Application
8 China
- 8.1 China Generic Injectables Breakdown Data by Company
- 8.2 China Generic Injectables Breakdown Data by Type
- 8.3 China Generic Injectables Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Generic Injectables Breakdown Data by Company
- 9.2 Rest of World Generic Injectables Breakdown Data by Type
- 9.3 Rest of World Generic Injectables Breakdown Data by Application
- 9.4 Rest of World Generic Injectables Breakdown Data by Countries
- 9.4.1 Rest of World Generic Injectables Sales by Countries
- 9.4.2 Rest of World Generic Injectables Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Generic Injectables
- 10.1.4 Generic Injectables Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Sandoz International
- 10.2.1 Sandoz International Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Generic Injectables
- 10.2.4 Generic Injectables Product Introduction
- 10.2.5 Sandoz International Recent Development
- 10.3 Baxter
- 10.3.1 Baxter Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Generic Injectables
- 10.3.4 Generic Injectables Product Introduction
- 10.3.5 Baxter Recent Development
- 10.4 Fresenius
- 10.4.1 Fresenius Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Generic Injectables
- 10.4.4 Generic Injectables Product Introduction
- 10.4.5 Fresenius Recent Development
- 10.5 Mylan
- 10.5.1 Mylan Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Generic Injectables
- 10.5.4 Generic Injectables Product Introduction
- 10.5.5 Mylan Recent Development
- 10.6 Teva Pharmaceutical
- 10.6.1 Teva Pharmaceutical Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Generic Injectables
- 10.6.4 Generic Injectables Product Introduction
- 10.6.5 Teva Pharmaceutical Recent Development
- 10.7 Hikma Pharmaceuticals
- 10.7.1 Hikma Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Generic Injectables
- 10.7.4 Generic Injectables Product Introduction
- 10.7.5 Hikma Pharmaceuticals Recent Development
- 10.8 Lupin Pharmaceuticals
- 10.8.1 Lupin Pharmaceuticals Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Generic Injectables
- 10.8.4 Generic Injectables Product Introduction
- 10.8.5 Lupin Pharmaceuticals Recent Development
- 10.9 Sanofi
- 10.9.1 Sanofi Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Generic Injectables
- 10.9.4 Generic Injectables Product Introduction
- 10.9.5 Sanofi Recent Development
- 10.10 Biocon
- 10.10.1 Biocon Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Generic Injectables
- 10.10.4 Generic Injectables Product Introduction
- 10.10.5 Biocon Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Generic Injectables Sales Channels
- 11.2.2 Generic Injectables Distributors
- 11.3 Generic Injectables Customers
12 Market Forecast
- 12.1 Global Generic Injectables Sales and Revenue Forecast 2019-2025
- 12.2 Global Generic Injectables Sales Forecast by Type
- 12.3 Global Generic Injectables Sales Forecast by Application
- 12.4 Generic Injectables Forecast by Regions
- 12.4.1 Global Generic Injectables Sales Forecast by Regions 2019-2025
- 12.4.2 Global Generic Injectables Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Generic Injectables. Industry analysis & Market Report on Generic Injectables is a syndicated market report, published as Global (United States, European Union and China) Generic Injectables Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Generic Injectables market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
